Safety and efficacy of bertilimumab, a human anti-eotaxin-1 monoclonal antibody, in bullous pemphigoid in a phase 2a studyA. S. Fiorino,S. Baum, A. Czernik,R. Hall,T. Zeeli, A. Baniel,A. A. Sinha, K. Seiffert-Sinha, B. Kolatch,Z. Zhang, E. SprecherJournal of Investigative Dermatology（2019）引用 7|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
